Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Mycophenolate (e.g. CellCept®): Strengthening of warnings in order to prevent use during pregnancy
2015.10.26
Active substance: mycophenolate
The European Medicines Agency (EMA) has issued a warning that the active substance mycophenolate used in transplantation medicine must not be administered during pregnancy if other treatment alternatives are available.
To the risk information - full text (available in German only)